Research demonstrates ability of thermostable nanoparticle design platform to tackle viral infections
New research has demonstrated the potential for the ADDomer platform to produce thermostable vaccines and reagents to tackle viral infections The study led by the University of Bristol and Imophoron, a biopharmaceutical company ...